Parameter | Year 1 | Year 2 | Year 3 | Cumulative |
---|---|---|---|---|
Cost of sitagliptin acquisition | 14,324,166 3,331,201 USD | 19,098,888 4,441,601 USD | 23,873,610 5,552,002 USD | 57,296,665 13,324,805 USD |
Cost of standard of care by substitutiona | (5,823,714) 1,354,352 USD | (7,764,952) 1,805,802 USD | (9,706,190) 2,257,253 USD | (23,294,856) 5,417,408 USD |
Drug cost | 8,500,452 1,976,849 USD | 11,333,936 2,635,799 USD | 14,167,420 3,294,748 USD | 34,001,809 7,907,397 USD |
MI | (277,509) 64,536 USD | (370,012) 86,049 USD | (462,515) 107,561 USD | (1,110,037) 258,148 USD |
Ischemic stroke | (476,953) 110,919 USD | (635,938) 151,413 USD | (794,922) 184,865 USD | (1,907,813) 443,677 USD |
Hospitalization for unstable angina | (555,019) 129,074 USD | (740,025) 172,098 USD | (925,031) 215,123 USD | (2,220,074) 516,296 USD |
Severe hypoglycemia | 87,453 20,337 USD | 116,605 27,117 USD | 145,756 33,896 USD | 349,814 81,352 USD |
CV death | 8,138,731 1,892,728 USD | 10,851,641 2,523,637 USD | 13,564,551 3,154,546 USD | 32,554,923 7,570,912 USD |
Hospitalization for heart failure or CV death | 583,273 135,644 USD | 777,697 180,859 USD | 972,121 226,074 USD | 2,333,091 542,579 USD |
Acute pancreatitis | 202,139 47,009 USD | 269,519 62,678 USD | 336,898 78,348 USD | 808,556 188,036 USD |
Pancreatic cancer | (333,276) 77,506 USD | (444,367) 103,341 USD | (555,459) 129,176 USD | (1,333,102) 310,023 USD |
Medical costs | 7,368,839 1,713,683 USD | 9,825,119 2,284,911 USD | 12,281,399 2,856,139 USD | 29,475,358 6,854,734 USD |
Total costs PPPM | 11 2.55 USD | 14 3.25 USD | 18 4.18 USD | 14 3.25 USD |